Stock Groups

Merck, Box Rose Premarket; Salesforce Falls -Breaking

by Mike Robinson

[ad_1]

© Reuters

Peter Nurse 

Investing.com — Premarket Trade on Wednesday, December 1, 2012: Stocks In Focus Refresh to see the most recent updates.

  • SalesforceThe stock of (NYSE) dropped 6.5% due to disappointing profit guidance for current quarter. This was in spite of fierce competition from Microsoft (NASDAQ). 

  • MerckThe stock price of the (NYSE: ) increased 0.8% as a panel representing the U.S. Food and Drug Administration voted in favor to authorize the drugmaker to make an antiviral treatment for Covid-19.

  • Box (NYSE:) stock rose 9.3% after the software company beat quarterly  expectations on both the top and bottom lines, helped by its performance in the Content Cloud market.

  • American Airlines(NASDAQ:) Stock rose 1.6% DeltaThe stock of (NYSE: ) rose 2.2% United(NASDAQ) Stock rose 1.8% because airlines rebounded while cruise companies declined Norwegian Cruise Line (NYSE:), Carnival(NYSE: Royal Caribbean (NYSE) All rose above 2.5%

  • Exxon Mobil The stock price of (NYSE:) rose 1.9% Chevron The stock price of (NYSE:) rose 2% Occidental PetroleumThe stock of (NYSE) rose 3.9% because crude prices increased more than 4 percent.

  • Allbirds The stock of (NASDAQ:) fell 4.7% as the retailer for shoes reported an even larger loss despite 33% increase in quarterly sales.

  • Hewlett Packard EnterpriseStock fell 1.4% on the NYSE after the company, an information technology firm, exceeded profit expectations for fiscal fourth quarter earnings. However it issued guidance regarding first quarter earnings that was light.

  • Ambarella(NASDAQ) Stock rose 15% on the news that the semiconductor company released a stronger-than-expected quarter-end report. The strong sales of computer-vision chips helped to propel it up. 

  • Lennar (NYSE:) stock rose 3.8% after Goldman Sachs (NYSE:) upgraded its investment stance on the real estate company to ‘buy’ from ‘neutral’, seeing 33% upside, thanks to sustained strong demand for new homes in the U.S.

  • DR Horton (NYSE:) stock fell 0.1% after Goldman downgraded its stance on the home construction company to ‘neutral’ from ‘buy’, saying upside in this stock is now limited.

 

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, futures, indexes and Forex. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]